Lopinavir/r versus nelfinavir as salvage therapy

被引：1
|
作者：
Resino, S [1 ]
Alvaro-Meca, A
de José, MI
Gurbindo, MD
Ramos, JT
Martin-Fontelos, P
Muñoz-Fernández, MA
机构：
[1] Hosp Gregorio Maranon, Lab Immuno Biol Mol, Madrid, Spain
[2] Hosp La Paz, Serv Pediat, La Paz, Bolivia
[3] Hosp Gregorio Maranon, Serv Inmuno Pediat, Madrid, Spain
[4] Hosp Carlos III, Serv Pediat Infecc, Madrid, Spain
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2005年 / 24卷 / 04期
关键词：
D O I：
10.1097/01.inf.0000157922.19139.90
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：392 / 393
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetic interaction between lopinavir/r and amprenavir in salvage therapy
    Basso, S
    Solas, C
    Quinson, AM
    Ravaux, I
    Poizot-Martin, I
    Bacconier, J
    Durand, A
    Lacarelle, B
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (01) : 115 - 117
  • [2] Drug interaction between amprenavir and lopinavir/r in salvage therapy
    Khanlou, H
    Graham, E
    Brill, M
    Farthing, C
    XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE, 2002, : 179 - 180
  • [3] Assessing treatment pattern and cost consequence of lopinavir/ritonavir versus nelfinavir therapy in HIV patients
    Luo, MP
    Boggs, R
    Bernstein, B
    Sun, E
    Ashraf, T
    ANTIVIRAL THERAPY, 2002, 7 (03) : L75 - L76
  • [4] A decision tree model comparing 6-month costs of lopinavir/r versus nelfinavir therapy using clinical trial data
    Luo, M
    Boggs, R
    Sun, E
    Ashraf, T
    AIDS, 2000, 14 : S102 - S103
  • [5] Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
    Walmsley, S
    Bernstein, B
    King, M
    Arribas, J
    Beall, G
    Ruane, P
    Johnson, M
    Johnson, D
    Lalonde, R
    Japour, A
    Brun, S
    Sun, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26): : 2039 - 2046
  • [6] Cost effectiveness of using lopinavir/ritonavir versus nelfinavir as the first highly active antiretroviral therapy regimen for HIV infection
    Simpson, KN
    Chumney, E
    Luo, MP
    Bernstein, B
    Sun, E
    Ashraf, T
    ANTIVIRAL THERAPY, 2002, 7 (03) : L77 - L77
  • [7] Transplacental passage of nevirapine, nelfinavir and lopinavir
    van Hoog, S.
    Boer, K.
    Nellen, J.
    Scherpbier, H.
    Godfried, M. H.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (02): : 102 - 103
  • [8] Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir
    Bates, DE
    Herman, RJ
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1190 - 1195
  • [9] Drug interaction between amprenavir and lopinavir/ritonavir in salvage therapy
    Khanlou, H
    Graham, E
    Brill, M
    Farthing, C
    AIDS, 2002, 16 (05) : 797 - 798
  • [10] Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection
    Simpson, KN
    Luo, MP
    Chumney, E
    Sun, E
    Brun, S
    Ashraf, T
    HIV CLINICAL TRIALS, 2004, 5 (05): : 294 - 304
12345